LLLT in the Lancet Top 20 Hit Parade

The paper by Roberta Chow, Mark Johnson, Rodrigo Lopes-Martins, Jan M Bjordal titled “Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trials” (abstract here) reached number 17 in The Lancet top 20 most downloaded papers for 2010. The full top 20 list is here:

1. Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
|FULL TEXT| 

2. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
|FULL TEXT| 

3. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
|FULL TEXT| 

4. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial
|FULL TEXT| 

5. Biological, clinical, and ethical advances of placebo effects
|FULL TEXT| 

6. Clinical assessment incorporating a personal genome
|FULL TEXT| 

7. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial
|FULL TEXT| 

8. Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
|FULL TEXT| 

9. Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial
|FULL TEXT| 

10. Ticagrelor in ACS: redefining a new standard of care?
|FULL TEXT| 

11. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial
|FULL TEXT| 

12. Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
|FULL TEXT| 

13. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial
|FULL TEXT| 

14. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension
|FULL TEXT| 

15. Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
|FULL TEXT| 

16. Ageing populations: the challenges ahead
|FULL TEXT| 

17. Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trials
|FULL TEXT| 

18. Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial
|FULL TEXT| 

19. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
|FULL TEXT| 

20. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
|FULL TEXT| 

THE LANCET ® is a registered trademark of Elsevier Properties SA, used under license.

About James Carroll

Founder and CEO at THOR Photomedicine Ltd. About THOR
This entry was posted in Industry. Bookmark the permalink.

Leave a Reply

Your email address will not be published.